J. Bashford

发表

Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study

W. Demark-Wahnefried, D. Battistutta, C. Saunders, 2015, BMC Cancer.

Design and implementation of the Exercise for Health trial -- a pragmatic exercise intervention for women with breast cancer.

E. Eakin, D. Battistutta, P. Yates, 2011, Contemporary clinical trials.

Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer

E. Eakin, D. Battistutta, P. Yates, 2012, Breast Cancer Research and Treatment.

Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up

E. Eakin, L. Gordon, C. Saunders, 2020, International journal of environmental research and public health.

Immunological changes after cancer treatment and participation in an exercise program.

P. S. Davies, J. Bashford, S. Hayes, 2003, Medicine and science in sports and exercise.

Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials

E. Eakin, D. Battistutta, L. Gordon, 2017, Breast Cancer Research and Treatment.

Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging

G. Scalia, J. Bashford, K. Newbigin, 2017, CASE.

Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia

J. Matthews, A. Schwarer, D. Gill, 2001, Leukemia.

Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards

J. Wale, J. Zalcberg, D. Currow, 2021, The Medical journal of Australia.

Donor-Derived b2a2-Specific T Cells for Immunotherapy of Patients with Chronic Myeloid Leukemia

S. Durrant, J. Bashford, M. Nieda, 2002, Journal of immunotherapy.

Phase II study of autologous stem cell transplant using busulfan–melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

H. Prince, A. Schwarer, D. Gill, 2010, Leukemia & lymphoma.

Prevalence and prognostic significance of secondary lymphedema following breast cancer.

D. Battistutta, J. A. Lopez, B. Newman, 2011, Lymphatic research and biology.

Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.

P. Francis, D. Rischin, H. Prince, 2002, Cytotherapy.

Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up.

C. Begley, J. Collins, J. Szer, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: A pilot study and literature review

P. Marlton, J. Seymour, D. Gill, 2005, Leukemia & lymphoma.

Cost-E ﬀ ectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up

E. Eakin, L. Gordon, C. Saunders, 2021 .

Multicycle H igh-Dose C hemotherapy a nd Filgrastim-Mobilized P eripheral-Blood P rogenitor C ells in W omen W ith H igh-Risk S tage I I o r I II B reast C ancer: Five-Year F ollow-Up

C. Begley, J. Collins, J. Szer, 1999 .

Social deprivation and patterns of consultation for respiratory symptoms: a population-based cohort study.

G. Thomas, M. Jones, P. Croft, 1999, Journal of epidemiology and community health.

Changes in nutritional status, body composition, quality of life, and physical activity levels of cancer patients undergoing autologous peripheral blood stem cell transplantation

J. Bauer, E. Isenring, M. Waterhouse, 2013, Supportive Care in Cancer.

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

L. Campbell, J. Reynolds, J. Szer, 2015, The Lancet. Haematology.

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.

J. Szer, J. Matthews, A. Schwarer, 2005, Blood.

Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor.

J. Bashford, A. Grigg, P. Mollee, 1999, Leukemia research.

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

R. Herrmann, D. Joske, J. Bashford, 2005, Bone Marrow Transplantation.

Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review

D. Langbecker, C. Sandler, J. Bashford, 2021, Journal of Neuro-Oncology.

Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemia.

J. Bashford, T. Olsen, C. Kelly, 1999, Australian and New Zealand journal of medicine.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

J. Reynolds, J. Szer, C. Tiley, 2012, Blood.

Role of a mixed type, moderate intensity exercise programme after peripheral blood stem cell transplantation

A. Green, P. S. Davies, J. Bashford, 2004, British Journal of Sports Medicine.

Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program

P. S. Davies, T. Parker, J. Bashford, 2004, Bone Marrow Transplantation.

Response of newly diagnosed myeloma with 1q21 amplification to bortezomib-based PAD induction therapy.

J. Szer, H. Prince, D. Joshua, 2010 .

Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim

S. Durrant, I. Lewis, J. Marty, 2003, Bone Marrow Transplantation.

Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all‐trans‐retinoic acid: suppression of the leukaemic clone

O. Garson, J. Szer, J. Wiley, 1991, British journal of haematology.

Body composition following stem cell transplant: comparison of bioimpedance and air-displacement plethysmography.

L. Ward, J. Bauer, E. Isenring, 2014, Nutrition.

Telephone-delivered nutrition and exercise counselling after auto-SCT: a pilot, randomised controlled trial

J. Coll, J. Bauer, E. Isenring, 2014, Bone Marrow Transplantation.

All-trans-retinoic acid , idarubicin , and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia ( APML 4 )

J. Reynolds, J. Szer, C. Tiley, 2012 .

Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme

P. S. Davies, J. Bashford, S. Hayes, 2003, Bone Marrow Transplantation.

Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors

G. Scalia, J. Bashford, K. Newbigin, 2017, International journal of cardiology. Heart & vasculature.

therapy in acute promyelocytic leukemia (APML4) -retinoic acid, idarubicin, and IV arsenic trioxide as initial trans All-

J. Reynolds, J. Szer, C. Tiley, 2013 .

CD5+, CD11C+, trap-positive chronic lymphocytic leukemia/prolymphocytic leukemia.

J. Bashford, H. Prince, M. van der Weyden, 1992, Blood.

Cost‐effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial

E. Eakin, D. Battistutta, P. Yates, 2017, Psycho-oncology.

The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation.

G. Scalia, J. Bashford, B. Fitzgerald, 2013, Heart, lung & circulation.

Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain

G. Scalia, J. Bashford, B. Fitzgerald, 2017, CASE.

The safety, feasibility, and efficacy of an 18-week exercise intervention for adults with primary brain cancer – the BRACE study

V. Biggs, M. Foote, C. Bettington, 2023, Disability and rehabilitation.

Intestinal infarction secondary to anti-thrombin III deficiency associated with cytomegalovirus infection.

J. Bashford, P. Kerlin, D. Schache, 1999, Australian and New Zealand journal of medicine.

Life‐threatening conjunctival presentation of myeloid sarcoma

K. Whitehead, J. Bashford, Graham A. Lee, 2008, Clinical & experimental ophthalmology.

Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation

J. Bauer, J. Bashford, P. Horsley, 2006, Supportive Care in Cancer.

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study

I. Kerridge, C. Tiley, S. Harrison, 2020 .

Activity and outcomes of autologous stem cell transplantation in the private sector in Australia

R. Ware, S. Durrant, I. Irving, 2022, Internal medicine journal.

Ageing, ethnicity and psychiatric services

Ajit K. Shah, J. Bashford, G. Oommen, 2009 .

Postnatal Development of Corticospinal Projections from Motor Cortex to the Cervical Enlargement in the Macaque Monkey

R N Lemon, R. Lemon, S. Edgley, 1997, The Journal of Neuroscience.

Postnatal Development of Corticospinal Projections from Motor Cortex to the Cervical Enlargement in the Macaque Monkey

R. Lemon, S. Edgley, E. Olivier, 1997, The Journal of Neuroscience.